FREQUENTLY ASKED
QUESTIONS

What is the difference between the Amgen FIRST STEP™ Program and the product-specific program?

The Amgen FIRST STEP™ Program is the main umbrella program under which each individual, product-specific program falls. For easy reference, the product-specific programs are referred to collectively as the Amgen FIRST STEP™ Program. All of the Amgen FIRST STEP™ Program eligibility requirements, terms, conditions, and limitations apply equally to all of the product-specific programs.

Do I have to enroll in both the Amgen FIRST STEP™ Program and the product-specific program?

No. Eligible patients enroll only in the product-specific program associated with their Amgen product.

Is there a limit or cap on Amgen FIRST STEP™ Program benefits?

  • Program covers out-of-pocket medication costs for the Amgen product only. Program does not cover any other costs related to office visit or administration of the Amgen product. Patient is responsible for costs above the maximum benefit amounts detailed below.
  • For Neulasta® (pegfilgrastim), Neulasta® Onpro® (pegfilgrastim), NEUPOGEN® (filgrastim), Nplate® (romiplostim), XGEVA® (denosumab), Vectibix® (panitumumab), IMLYGIC® (talimogene laherparepvec), and BLINCYTO® (blinatumomab) : no out-of-pocket cost for first dose or cycle; $5 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $10,000 per patient per calendar year.
  • For KYPROLIS®: no out-of-pocket cost for first dose or cycle; $5 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $20,000 per patient per calendar year.
  • For Prolia®: no out-of-pocket cost for first dose or cycle; $25 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $1,500 per patient per calendar year.
  • Ongoing activation of the Amgen FIRST STEP™ card is contingent on the submission of the required Explanation of Benefits (EOB) form by the healthcare provider's office within 45 days of use of the Amgen FIRST STEP™ card. Patients will be responsible for reimbursing the program for all amounts paid out if the EOB for the date of service is not received within 45 days.

Can the Amgen FIRST STEP™ Program MasterCard® be used with mail order and specialty pharmacies?

Yes, the Amgen FIRST STEP™ Program can be used at pharmacies. Simply provide the RxBIN number and member ID that is printed on the card when filling your prescription.

What if there is a delay in getting the EOB?

If EOB is not received within 45 days, the card will be deactivated. Patients will be responsible for reimbursing the program for all amounts paid out if the EOB for the date of service is not received within 45 days. If you require any further extension on a specific case, call the Help Desk at 1-888-65-STEP1 (1-888-657-8371).

Is annual re-enrollment in the Amgen FIRST STEP™ Program necessary?

Once registered in the Amgen FIRST STEP™ Program, there is no re-enrollment necessary.

Why are uninsured cash-paying patients not eligible for the Amgen FIRST STEP™ Program?

The Amgen FIRST STEP™ Program is intended to help commercially insured patients cover the cost of their co-insurance or co-payment obligations for Neulasta®, Neulasta® Onpro®, NEUPOGEN®, Nplate®, XGEVA®, Vectibix®, IMLYGIC®, and BLINCYTO®. Uninsured patients requiring assistance may contact The Safety Net Foundation at 1-888-SN-AMGEN to request assistance.

Why do I need to provide my Social Security Number to enroll?

We need your Social Security Number in order to confirm that you are not in a government-funded healthcare program. Your number will only be used to verify this information and will not be used for any other purpose.

Does the Explanation of Benefits (EOB) have to be faxed after each dose?

Ongoing eligibility in the program is contingent on submission of the patient's EOB within 45 days of each and every swipe of Amgen FIRST STEP™ card. To submit EOB and other relevant documentation, please fax 1-866-653-2972 or mail to: ConnectiveRx at 100 Passaic Avenue, Suite 245, Fairfield, NJ 07004 - ATTN: Amgen FIRST STEP™ Program.

Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide for BLINCYTO®.
Please see Full Prescribing Information, including Boxed WARNINGS, for Vectibix®.